Načítá se...
Augmenting extinction learning with d-cycloserine reduces return of fear: a randomized, placebo-controlled fMRI study
d-cycloserine (DCS), a partial NMDA-receptor agonist, seems to be a promising enhancer for exposure therapy in anxiety disorders. It has been tested successfully in animal models of fear extinction, where DCS enhanced extinction learning. Applied in clinical studies, results of DCS-augmented exposur...
Uloženo v:
| Vydáno v: | Neuropsychopharmacology |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6969173/ https://ncbi.nlm.nih.gov/pubmed/31634897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0552-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|